Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
D-N-Acetylgalactosamine Protocol and QC Guide
2026-09-04
D-N-Acetylgalactosamine (SKU B7904) provides a defined, high-purity reagent for glycoprotein composition studies, brain heteropolysaccharides analysis, and related glycosylation pathway workflows. It is suitable for aqueous or validated DMSO preparations, but not for ethanol-based protocols or long-term storage of prepared solutions.
-
JC-1 Assay Connects Mitochondria to Tumor Angiogenesis
2026-09-04
A mechanistic perspective on how mitochondrial membrane potential measurement can strengthen translational studies of LRG1-driven neutrophil dysfunction, NETosis, vascular instability, and treatment resistance in bladder cancer. The article positions the JC-1 Mitochondrial Membrane Potential Assay Kit as a practical ratiometric tool for linking mitochondrial state to apoptosis, mitochondrial function analysis, and therapeutic response while defining the controls and orthogonal assays needed for credible interpretation.
-
Apicidin Disrupts Oocyte Quality via Histone Acetylation
2026-09-03
A 2026 study shows that Apicidin exposure impairs oocyte meiotic maturation by disrupting spindle assembly, chromosome alignment, actin organization, and histone acetylation. The work connects HDAC-associated epigenetic changes with structural defects, DNA damage, and early apoptosis, providing a focused framework for evaluating the reproductive toxicity of this emerging mycotoxin.
-
UK-5099: A Translational Lever for Immunometabolism
2026-09-03
UK-5099, also known as PF-1005023, turns mitochondrial pyruvate entry into a controllable variable for mitochondrial metabolism research, immune assays, and glucose-homeostasis studies.
-
Pollen Interference in Bioaerosol EEM Analysis
2026-09-02
The reference study shows that pollen can distort excitation–emission matrix fluorescence classification of hazardous bioaerosol components because its strong emission resembles biological signatures. Combining spectral preprocessing, fast Fourier transform feature conversion, and random forest classification improved discrimination across 31 sample types and offers a practical strategy for rapid screening.
-
Tacrine-Based Hybrids: Evidence and Design Lessons
2026-09-02
This review maps tacrine-based hybrid molecules developed between 2006 and 2022, emphasizing multi-target strategies that combine cholinesterase inhibition with activity against amyloid, oxidative, metal-related, inflammatory, or kinase-associated mechanisms. Its main practical contribution is a design framework for retaining the potency of the tacrine scaffold while addressing hepatotoxicity and the multifactorial biology of Alzheimer’s disease.
-
FK866 (APO866) for NAD-Driven Cancer Assays
2026-09-01
FK866 (APO866) enables mechanism-led studies of NAMPT dependence, NAD depletion, mitochondrial injury, and selective cancer-cell vulnerability. This workflow-focused guide shows how to deploy it in hematologic cancer research and how to adapt the NAD axis to platinum and PARP inhibitor resistance models without overstating cross-tumor evidence.
-
D-N-Acetylgalactosamine: Protocol and QC Guide
2026-09-01
D-N-Acetylgalactosamine (SKU B7904) provides a defined, high-purity reagent for aqueous workflows examining glycoprotein constituents, brain heteropolysaccharides, and related glycosylation studies. It is suitable for water or compatible DMSO preparations, but not for ethanol-based protocols or long-term storage of prepared solutions.
-
CFTRinh-172: Selective CFTR Inhibitor Guide
2026-08-31
CFTRinh-172 is a selective CFTR inhibitor for measuring cAMP-activated chloride transport in epithelial research. Product information reports rapid, reversible, voltage-independent inhibition and a mouse result showing more than 90% suppression of cholera toxin-induced intestinal fluid secretion at 250 μg/kg.
-
Nano-Granulated Zoledronate Reprograms Immunity
2026-08-31
Chen et al. develop Nano-ZD, a nano-granulated zoledronate formulation that redirects mevalonate-pathway modulation toward lymph node innate immune cells. The study links CoQ depletion to OXPHOS, pyrimidine metabolism, MAVS, and inflammasome signaling, while showing enhanced vaccine and antitumor responses when Nano-ZD is combined with MPLA or αPD-L1.
-
HyperScript III RT SuperMix for CRC qPCR
2026-08-30
Turn low-input, high-GC colorectal cancer RNA into cleaner cDNA for targeted biomarker validation. HyperScript III RT SuperMix combines high-efficiency reverse transcription with genomic DNA contamination removal, supporting reproducible SYBR Green or probe-based qPCR workflows.
-
Fosinopril Sodium: From PK to Assay Design
2026-08-29
Fosinopril sodium is an ACE inhibitor whose prodrug activation and dual-route elimination create important assay-design variables. This guide translates clinical pharmacokinetic evidence into practical strategies for hypertension research, cardiovascular disease models, and renal hemodynamics studies.
-
KR-12–Cu(II) Binding: Theory Meets Experiment
2026-08-28
The 2024 Dalton Transactions study combines GFN2-xTB/ALPB calculations with potentiometric titration and isothermal titration calorimetry to resolve how KR-12 peptides interact with Cu(II). Its central finding is that peptide-backbone oxygen atoms dominate favorable coordination, while aspartic acid and Arg29 strongly influence the interaction landscape.
-
YBX1–SHANK3 Methylation in Schizophrenia
2026-08-28
The reference study connects SHANK3 promoter hypermethylation in peripheral blood mononuclear cells with cortical structure and negative symptoms in first-episode schizophrenia. Its cell-type-specific experiments further identify YBX1 as a positive regulator of SHANK3 in induced pluripotent stem cell-derived cortical interneurons, offering a mechanistic bridge between peripheral epigenetic signals and neurodevelopmental biology.
-
PreScission Protease for Condensate-Ready Purification
2026-08-27
PreScission Protease enables site-specific fusion-tag removal under cold, protein-preserving conditions. This workflow connects native-protein recovery with practical assay design for Drosophila Keap1 condensate studies, where tag status can influence interpretation.